Researchers at the University of Michigan are collaborating with national partners to develop new technologies aimed at improving how drug safety is evaluated before clinical trials. The project combines human organoid models, advanced imaging, and artificial intelligence to study how potential medicines interact with human biology. This work is part of a broader national effort to modernize drug development and reduce failures in early testing.
